DifGen Pharma, Aveva Lead U.S. PASC Immune Therapy Collaboration
25 Mar 2026 //
PR NEWSWIRE
Biostax To Voluntarily Delist From OTC Pink & Deregister With SEC
21 Feb 2025 //
GLOBENEWSWIRE
Biostax Announces Director Appointment of Influential Business Leader Craig Suro
15 Nov 2023 //
GLOBENEWSWIRE
Biostax Announces Appointment of Ms. Mary Clay Caperton to Board of Directors
02 Nov 2023 //
GLOBENEWSWIRE
Biostax Announces FINRA Approval for Name and Ticker Symbol Change
24 Oct 2023 //
GLOBENEWSWIRE
Biostax Corp. Signs CollabAgreement with Immgenuity to Pursue Remission in HIV
29 Aug 2023 //
GLOBENEWSWIRE

Market Place
Sourcing Support